Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Gamelin, L. Gamelin, L. Bossi, S. Quasthoff (2002)
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures.Seminars in oncology, 29 5 Suppl 15
D. Baker (2003)
Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.Reviews in gastroenterological disorders, 3 1
V. Noronha, B. Burtness, J. Murren, T. Duffy (2005)
Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature.Clinical colorectal cancer, 5 4
F. Grolleau, L. Gamelin, M. Boisdron-Celle, B. Lapied, M. Pelhate, E. Gamelin (2001)
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.Journal of neurophysiology, 85 5
I. Hart, C. Waters, A. Vincent, C. Newland, D. Beeson, O. Pongs, C. Morris, J. Newsom-Davis* (1997)
Autoantibodies detected to expressed K+ channels are implicated in neuromyotoniaAnnals of Neurology, 41
A. Krishnan, D. Goldstein, M. Friedlander, M. Kiernan (2005)
Oxaliplatin‐induced neurotoxicity and the development of neuropathyMuscle & Nerve, 32
J. Newsom-Davis*, C. Buckley, L. Clover, I. Hart, P. Maddison, Erdem Tüzüm, A. Vincent (2003)
Autoimmune Disorders of Neuronal Potassium ChannelsAnnals of the New York Academy of Sciences, 998
H. Adelsberger, S. Quasthoff, J. Grosskreutz, A. Lepier, F. Eckel, C. Lersch (2000)
The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.European journal of pharmacology, 406 1
J. Heckman (1984)
Electrodiagnosis in diseases of nerve and muscle.Orthopedics, 7 4
T. Lehky, G. Leonard, R. Wilson, J. Grem, M. Floeter (2004)
Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathyMuscle & Nerve, 29
Jane Choi, K. Kong, T. Mozaffar, R. Holcombe (2006)
Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer.Anti-cancer drugs, 17 1
Background: To date, only a few cases have been reported that indicate that a delayed polyneuropathy may occur after chemotherapy with oxaliplatin. The clinical and electrophysiological manifestations of this delayed neurotoxicity have never been well documented. Case Reports: Nerve conduction studies were performed in 4 patients who developed acute peripheral neuropathy several months after completion of oxaliplatin-containing chemotherapy. Sensory nerve conduction was abnormal in all patients. In 2 patients, the electrodiagnostic studies showed a mixed axonal and demyelinating sensorimotor polyneuropathy. Conclusions: Delayed polyneuropathy occurring after oxaliplatin-based chemotherapy can be confirmed by electrophysiological studies.
Oncology Research and Treatment – Karger
Published: Jan 1, 2009
Keywords: Oxaliplatin; Polyneuropathy; Neurotoxicity
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.